UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.186

Sortiert nach

Decoding kinase-adverse event associations for small molecule kinase inhibitors

Nature communications, 2022-07, Vol.13 (1), p.4349-4349, Article 4349

2022

Link zum Volltext

Verfügbarkeit prüfen

From big data to smart data: FDA's INFORMED initiative

Nature reviews. Drug discovery, 2017-02, Vol.16 (5), p.306-306

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the potential for digital submission of expedited premarket safety reports to the FDA

Nature reviews. Drug discovery, 2016-09, Vol.15 (10), p.670-671

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Development of Cancer Drugs in Combination With External Beam Radiation Therapy: US Food and Drug Administration Perspective

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.5-7

2017

Link zum Volltext

Verfügbarkeit prüfen

FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the U.S. Food and Drug Administration

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.10009-10009

2017

Link zum Volltext

Verfügbarkeit prüfen

21st Century Cardio-Oncology

JACC. Basic to translational science, 2016-08, Vol.1 (5), p.386-398

2016

Link zum Volltext

Verfügbarkeit prüfen

FDA analysis of patients with baseline autoimmune diseases treated with PD-1/PD-L1 immunotherapy agents

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3018-3018

2017

Link zum Volltext

Verfügbarkeit prüfen

FDA analysis of patient enrollment by region in clinical trials for approved oncological indications

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2539-2539

2017

Link zum Volltext

Verfügbarkeit prüfen

Successes and Challenges of PARP Inhibitors in Cancer Therapy

Frontiers in oncology, 2015-10, Vol.5, p.222-222

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor progression versus bone scan “flare” in new lesions detected on early bone scans in patients with chemo-naïve metastatic castration resistant prostate cancer (mCRPC) treated with placebo or enzalutamide

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.305-305

2016

Link zum Volltext

Verfügbarkeit prüfen

Association of clinical benefit rate (CBR) with survival: A pooled-analysis of metastatic breast cancer (MBC) trials submitted to the U.S. Food and Drug Administration (FDA)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18091-e18091

2016

Link zum Volltext

Verfügbarkeit prüfen

FDA analysis of treatment beyond disease progression disease (PD) in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab vs. everolimus

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4508-4508

2016

Link zum Volltext

Verfügbarkeit prüfen

Landscape of cancer clinical trials in India – a comprehensive analysis of the Clinical Trial Registry-India

The Lancet regional health. Southeast Asia, 2024-05, Vol.24, p.100323-100323, Article 100323

2024

Link zum Volltext

Verfügbarkeit prüfen

‘Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials’- Authors Response to Letter

Clinical cancer research, 2016-11, Vol.22 (22), p.5618-5618

2016

Link zum Volltext

Verfügbarkeit prüfen

FDA subset analysis of the safety of nivolumab in elderly patients with advanced cancers

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.10010-10010

2016

Link zum Volltext

Verfügbarkeit prüfen

A U.S. Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.570-570

2016

Link zum Volltext

Verfügbarkeit prüfen

FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone ReceptorPositive, HER2-Negative Metastatic Breast Cancer

Clinical cancer research, 2016-10, Vol.22 (20), p.4968-4972

2016

Link zum Volltext

Verfügbarkeit prüfen

21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine

JACC. Basic to translational science, 2016-08, Vol.1 (5), p.386-398

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer

Bladder cancer, 2015-01, Vol.1 (2), p.133-136

2015

Link zum Volltext

Verfügbarkeit prüfen

Proteomics and ovarian cancer: Integrating proteomics information into clinical care : Current status of cancer proteomics, how far are we from clinical application

Journal of proteomics, 2010, Vol.73 (10), p.1864-1872

2010

Link zum Volltext

Verfügbarkeit prüfen

Employment Location in Cities and Regions: Models and Applications

1. Aufl., 2012

Link zum Volltext

Verfügbarkeit prüfen

Analyzing Microarray Gene Expression Data

1. Aufl., 2005

Link zum Volltext

Verfügbarkeit prüfen

A Proposal of Deciding Fatigue Strength in Bending Fatigue Test

机械工程与自动化：英文版, 2014, Vol.4 (2), p.158-164

You-Chul Kim Mikihito Hirohata Geoffrey Mutyaba Hun-Sur Bang

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients

Journal of clinical microbiology, 2018-11, Vol.56 (11)

2018

Link zum Volltext

Verfügbarkeit prüfen

Carbon Nanotube Yarn for Fiber‐Shaped Electrical Sensors, Actuators, and Energy Storage for Smart Systems

Advanced materials (Weinheim), 2020-02, Vol.32 (5), p.e1902670-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.186

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(988)
Mit Volltextzugriff
(1.109)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(545)
Life Sciences & Biomedicine
(315)
Technology
(157)
Physical Sciences
(145)
Animals
(76)
Chemistry
(75)
Science & Technology - Other Topics
(65)
Engineering
(57)
Materials Science
(57)
Physics
(54)
Exact Sciences And Technology
(49)
Social Sciences
(49)
Materials Science, Multidisciplinary
(46)
Biological And Medical Sciences
(45)
Chemistry, Physical
(37)
Oncology
(36)
Biochemistry & Molecular Biology
(35)
Computer Science
(35)
Multidisciplinary Sciences
(35)
Chemistry, Multidisciplinary
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Decoding kinase-adverse event associations for small molecule kinase inhibitors

From big data to smart data: FDA's INFORMED initiative

Evaluating the potential for digital submission of expedited premarket safety reports to the FDA

Clinical Development of Cancer Drugs in Combination With External Beam Radiation Therapy: US Food and Drug Administration Perspective

FDA analysis of enrollment of older adults in clinical trials for cancer drug registration: A 10-year experience by the U.S. Food and Drug Administration

21st Century Cardio-Oncology

FDA analysis of patients with baseline autoimmune diseases treated with PD-1/PD-L1 immunotherapy agents

FDA analysis of patient enrollment by region in clinical trials for approved oncological indications

Successes and Challenges of PARP Inhibitors in Cancer Therapy

Tumor progression versus bone scan “flare” in new lesions detected on early bone scans in patients with chemo-naïve metastatic castration resistant prostate cancer (mCRPC) treated with placebo or enzalutamide

Association of clinical benefit rate (CBR) with survival: A pooled-analysis of metastatic breast cancer (MBC) trials submitted to the U.S. Food and Drug Administration (FDA)

FDA analysis of treatment beyond disease progression disease (PD) in patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab vs. everolimus

Landscape of cancer clinical trials in India – a comprehensive analysis of the Clinical Trial Registry-India

‘Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials’- Authors Response to Letter

FDA subset analysis of the safety of nivolumab in elderly patients with advanced cancers

A U.S. Food and Drug Administration (FDA) pooled analysis of outcomes for bone only metastatic breast cancer (MBC)

FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone ReceptorPositive, HER2-Negative Metastatic Breast Cancer

21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine

Development of Systemic and Topical Drugs to Treat Non-muscle Invasive Bladder Cancer

Proteomics and ovarian cancer: Integrating proteomics information into clinical care : Current status of cancer proteomics, how far are we from clinical application

Employment Location in Cities and Regions: Models and Applications

Analyzing Microarray Gene Expression Data

A Proposal of Deciding Fatigue Strength in Bending Fatigue Test

Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients

Carbon Nanotube Yarn for Fiber‐Shaped Electrical Sensors, Actuators, and Energy Storage for Smart Systems

Aktive Filter

Suchergebnisse filtern